In the title compound, C 21 H 17 N 3 O 2 , the 2-hydroxy-5-methylphenyl ring and the phenyl ring are inclined to the mean plane of the pyrazolopyridine moiety (r.m.s. deviation = 0.013 Å ) by 52.89 (9) and 19.63 (8) , respectively, and to each other by 42.83 (11) . In the molecule, there are intramolecular O-HÁ Á ÁO and C-HÁ Á ÁN hydrogen bonds, both enclosing an S(6) ring motif. In the crystal, molecules stack along the c-axis direction, forming columns within which there are a number of -interactions [the inter-centroid distances vary from 3.5278 (10) to 3.8625 (10) Å ]. The columns are linked by C-HÁ Á Á interactions, forming slabs parallel to (100).
Related literature
For some details of the biological activity of pyrazole derivatives, see: Burger & Iorio (1979 , 1980 ; Kalluraya & Ramesh (2001) ; Windholz (2003) . For the antibacterial activity of propenones, see : Holla et al. (1994) . For details of the pyrazole moiety found in blockbuster drugs, see : Penning et al. (1997) for celecobix; Terrett et al. (1996) for sildenafil; Seltzman et al. (1995) for rimonabant. Table 1 Hydrogen-bond geometry (Å , ).
Experimental

Crystal data
Cg3 and Cg4 are the centroids of rings C1-C4/C6/C7 and C16-C21, respectively. Data collection: APEX2 (Bruker, 2008 ); cell refinement: SAINT (Bruker, 2008) ; data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 for Windows (Farrugia, 2012) ; software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009 ).
S1. Comments
Pyrazole derivatives are reported to possess varied biological activities such as anti-inflammatory (Windholz, 2003) , analgesic (Windholz, 2003) , hypoglysemic, seditive (Burger et al., 1979) , hypnotic (Burger et al., 1980) , antifungal and antibacterial (Kalluraya & Ramesh, 2001) activities. Propenones are also found to show good antibacterial activity (Holla et al., 1994) . The pyrazole moiety is found in blockbuster drugs such as celecobix (Penning et al., 1997) , sildenafil (Terrett et al., 1996) and rimonabant (Seltzmann et al., 1995) .
The molecular structure of the title molecule is shown in Fig forming slabs parallel to (100).
S2. Synthesis and crystallization
To a mixture of 3-formylchromone and 5-amino-3-methyl-1-phenyl pyrazole in ethanol, was added a catalytic amount of In(OTf) 3 and the resulting mixture was refluxed for ca. 20 min. The precipitate formed was filtered and dried under vacuum to afford the pure title product (yield: 87%). It was recrystallized from ethanol and DMSO-D 6 by slow evaporation over 48 h, giving colourless block-like crystals.
S3. Refinement
Crystal data, data collection and structure refinement details are summarized in Table 2 . The O-and C-bound H atoms were positioned geometrically and allowed to ride on their parent atoms: O-H = 0.82 Å, C-H = 0.93-0.96 Å with U iso (H) = 1.5U eq (O,C) for the hydroxyl and methyl H atoms and 1.2U eq (C) for other H atoms.
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Figure 1
The molecular structure of the title compound, with atom labelling. Displacement ellipsoids are drawn at the 30% probability level. Intramolecular hydrogen bonds are shown as dashed lines (see Table 1 for details)
Figure 2
The crystal packing of the title compound, viewed along the c axis. The O-H···O and C-H···π interactions are shown as dashed lines (see Table 1 for details). ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger. 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (
